| [1] |
Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: a practical update[J]. Virulence, 2016, 7(3):280–97.
|
| [2] |
Lo Menzo S, la Martire G, Ceccarelli G, et al. New insights on epidemiology and management of bacterial bloodstream infection in patients with hematological malignancies[J]. Mediterr J Hematol Infect Dis, 2015, 7(1):e2015044.
|
| [3] |
Kulkarni AP. Immunocompromised hosts: infections and biomarkers[J]. South Asian J Cancer, 2013, 2(4):209–210.
|
| [4] |
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definition of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group[J]. Clin Infect Dis, 2008, 46(12):1813–1821.
|
| [5] |
Williams MD, Braun LA, Cooper LM, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care[J]. Crit Care, 2004, 8(5):R291–R298.
|
| [6] |
Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients[J]. Clin Microbiol Infect, 2013, 19(5):474–479.
|
| [7] |
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 52(4):427–431.
|
| [8] |
Herbers AH, de Haan AF, van der Velden WJ, et al. Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients[J]. Transpl Infect Dis, 2014, 16(2):279–285.
|
| [9] |
Bouza E, Burillo A, Guembe M. Managing intravascular catheter-related infections in heart transplant patients: how far can we apply IDSA guidelines for immunocompromised patients[J]. Curr Opin Infect Dis, 2011, 24(4):302–308.
|
| [10] |
Cordonnier C, Buzyn A, Leverger G, et al. Epidemiology and risk factors for Gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy[J]. Clin Infect Dis, 2003, 36(2):149–158.
|
| [11] |
Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients[J]. J Clin Oncol, 2000, 18(16):3038–3051.
|
| [12] |
Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5):426–435.
|
| [13] |
Paolucci M, Stanzani M, Medlchlonda F, et al. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients[J]. Diagn Microbiol Infect Dis, 2013, 75(2):130–134.
|
| [14] |
Tissari P, Zumla A, Tarkka E, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study[J]. Lancet, 2010, 375(9710):224–230.
|
| [15] |
Vincent JL, Brealey D, Libert N, et al. Rapid diagnosis of infection in the critically ill: a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections[J]. Crit Care Med, 2015, 43(11):2283–2291.
|
| [16] |
Varani S, Stanzani M, Paolucci M, et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR[J]. J Infect, 2009, 58(5):346–351.
|
| [17] |
Paul M, Dickstein Y, Borok S, et al. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer[J]. Cochrane Database Syst Rev, 2014, 14(1):CD003914.
|
| [18] |
Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia[J]. Haematologica, 2013, 98(12):1826–1835.
|
| [19] |
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 49(1):1–45.
|